Form 4 for CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE
Accepted 2026-09-18 16:22:45 ET · period of report 2026-09-17 · accession 0001839066-26-000047 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-09-18 16:22 | 2026-09-17 | CLOV | Reynoso Jamie L. | CEO, Medicare Advantage | S - Sale | $4.56 | -1,921 | 2.80M | -0.1% | -$8,760 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2026-09-17 | S | D | 1,921 | $4.56 | 2,803,446 | D | — | — | (F1) The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026. |